11:44 AM EST - NeutriSci International Inc. : And Lexaria Bioscience Corp. announced finalization of the joint venture between the companies to produce and commercialize a line of healthy, sugar-free, edible cannabinoid sublingual tablets combining NeutriSci's proprietary pterostilbene tablet form factor and Lexaria's patented technology. NeutriSci International Inc.
shares V.NU are trading up $0.05 at $0.18.
